Zacks Investment Research · ENTA · November 16, 2026Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue EstimatesGet the app for moreExplore stock news, insights and company research.Get the app →Source: Zacks Investment Research ↗